Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Aclaris Therapeutics (ACRS) Institutional Ownership

Aclaris Therapeutics logo
$4.54 +0.01 (+0.22%)
Closing price 04:00 PM Eastern
Extended Trading
$4.54 +0.00 (+0.11%)
As of 04:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Aclaris Therapeutics (NASDAQ:ACRS)

Current
Institutional Ownership
Percentage
98.34%
Number of
Institutional Buyers
(last 12 months)
56
Total
Institutional Inflows
(last 12 months)
$30.84M
Number of
Institutional Sellers
(last 12 months)
31
Total
Institutional Outflows
(last 12 months)
$40.81M
Get ACRS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aclaris Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ACRS Institutional Buying and Selling by Quarter

Aclaris Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/20/2026 Vivo Capital LLC6,666,666$25M2.1%-25.0%4.773%
5/19/2026 Bank of America Corp DE79,539$298K0.0%+23.3%0.057%
5/18/2026 ADAR1 Capital Management LLC132,426$497K0.0%-78.4%0.095%
5/18/2026 Rock Springs Capital Management LP4,472,650$16.77M1.0%+0.4%3.203%
5/16/2026 The Manufacturers Life Insurance Company 25,398$95K0.0%-12.4%0.018%
5/16/2026 Kalehua Capital Management LLC1,832,365$6.87M4.9%N/A1.312%
5/14/2026 Renaissance Technologies LLC502,631$1.89M0.0%-55.3%0.360%
5/14/2026 Bollard Group LLC431,631$1.62M0.0%-46.3%0.309%
5/14/2026 Sei Investments Co.217,154$814K0.0%N/A0.155%
5/14/2026 Monashee Investment Management LLC500,000$1.88M1.0%N/A0.358%
5/7/2026 Aldebaran Capital LLC947,162$3.55M2.7%-0.7%0.678%
5/7/2026 Dimensional Fund Advisors LP511,461$1.91M0.0%+88.8%0.366%
5/5/2026 Bank of New York Mellon Corp207,024$776K0.0%+1.7%0.148%
4/25/2026 Strs Ohio16,000$60K0.0%N/A0.013%
4/20/2026 Assenagon Asset Management S.A.177,283$665K0.0%+14.7%0.147%
4/16/2026 SG Americas Securities LLC26,767$100K0.0%+73.6%0.022%
4/16/2026 Diversified Trust Co29,455$110K0.0%N/A0.024%
2/26/2026 Seven Fleet Capital Management LP107,419$323K0.2%N/A0.099%
2/19/2026 Invesco Ltd.209,903$632K0.0%+29.2%0.194%
2/18/2026 XTX Topco Ltd112,912$340K0.0%+76.6%0.104%
2/18/2026 Wellington Management Group LLP264,359$796K0.0%N/A0.244%
2/18/2026 Susquehanna Portfolio Strategies LLC39,701$120K0.0%N/A0.037%
2/18/2026 Quadrature Capital Ltd57,670$174K0.0%+82.8%0.053%
2/18/2026 Millennium Management LLC1,053,246$3.17M0.0%-32.2%0.972%
2/18/2026 Man Group plc42,435$128K0.0%N/A0.039%
2/18/2026 Bridgeway Capital Management LLC330,019$993K0.0%-16.1%0.305%
2/17/2026 Logos Global Management LP600,000$1.81M0.1%-60.0%0.554%
2/17/2026 ADAR1 Capital Management LLC613,986$1.85M0.1%+64.3%0.567%
2/17/2026 AQR Capital Management LLC103,792$312K0.0%+197.0%0.096%
2/17/2026Kotler Kevin1,705,929$5.14M1.2%N/A1.574%
2/17/2026 Rock Springs Capital Management LP4,453,741$13.41M0.7%-3.4%4.111%
2/17/2026 Adage Capital Partners GP L.L.C.3,371,000$10.15M0.0%-36.1%3.111%
2/17/2026 Persistent Asset Partners Ltd22,259$67K0.0%N/A0.021%
2/16/2026 Panagora Asset Management Inc.68,190$205K0.0%+49.6%0.063%
2/16/2026 Barclays PLC143,414$432K0.0%+16.2%0.132%
2/16/2026 Bollard Group LLC804,445$2.42M0.1%-34.4%0.742%
2/13/2026 Marshall Wace LLP485,501$1.46M0.0%-71.7%0.448%
2/13/2026 The Manufacturers Life Insurance Company 28,998$87K0.0%-13.4%0.027%
2/13/2026 Charles Schwab Investment Management Inc.284,604$857K0.0%+17.6%0.263%
2/13/2026 State Street Corp1,506,403$4.53M0.0%+35.3%1.390%
SpaceX eyes a 1.75 trillion valuation - here's what to know (Ad)

Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.tc pixel

See how to get positioned in SpaceX before the announcement goes public
2/13/2026 Wells Fargo & Company MN104,465$314K0.0%+53.5%0.096%
2/12/2026 Jane Street Group LLC27,216$82K0.0%-62.8%0.025%
2/12/2026 MetLife Investment Management LLC25,597$77K0.0%-27.5%0.024%
2/12/2026 Aldebaran Capital LLC954,262$2.87M2.6%-3.4%0.881%
2/12/2026 Renaissance Technologies LLC1,125,331$3.39M0.0%-30.5%1.039%
2/12/2026 Dimensional Fund Advisors LP270,850$815K0.0%+64.9%0.250%
2/12/2026 New York State Common Retirement Fund27,300$82K0.0%-43.6%0.025%
2/12/2026 Alps Advisors Inc.88,966$268K0.0%N/A0.082%
2/11/2026 Deutsche Bank AG987,351$2.97M0.0%+6.9%0.911%
2/10/2026 CIBC Asset Management Inc17,428$52K0.0%N/A0.016%
2/10/2026 Goldman Sachs Group Inc.632,502$1.90M0.0%-33.8%0.584%
2/10/2026 AXQ Capital LP24,186$73K0.0%+73.1%0.022%
2/10/2026 Intech Investment Management LLC46,646$140K0.0%+19.8%0.043%
2/9/2026 Geode Capital Management LLC2,392,772$7.20M0.0%+0.1%2.208%
2/6/2026 ProShare Advisors LLC21,553$65K0.0%+45.4%0.020%
2/6/2026 HighTower Advisors LLC305,948$921K0.0%-1.1%0.282%
2/4/2026 Valeo Financial Advisors LLC27,540$83K0.0%N/A0.025%
1/30/2026 R Squared Ltd12,408$37K0.0%N/A0.011%
1/29/2026 China Universal Asset Management Co. Ltd.17,655$53K0.0%N/A0.016%
1/9/2026 SG Americas Securities LLC15,423$46K0.0%-29.9%0.014%
1/1/2026 JPMorgan Chase & Co.758,576$1.44M0.0%+21.6%0.700%
11/17/2025 Susquehanna International Group LLP36,237$69K0.0%-70.1%0.033%
11/17/2025 Qube Research & Technologies Ltd544,760$1.04M0.0%+7.0%0.503%
11/17/2025 Palo Alto Investors LP1,566,840$2.98M0.6%+12.7%1.446%
11/17/2025 Millennium Management LLC1,554,458$2.95M0.0%-59.5%1.435%
11/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.42,755$81K0.0%-13.8%0.039%
11/17/2025 Bollard Group LLC1,225,476$2.33M0.1%-9.4%1.131%
11/17/2025 Citadel Advisors LLC1,432,677$2.72M0.0%+25.3%1.322%
11/17/2025 Algert Global LLC65,630$125K0.0%+64.7%0.061%
11/17/2025 Ameriprise Financial Inc.1,277,817$2.43M0.0%N/A1.179%
11/14/2025 Raymond James Financial Inc.283,476$539K0.0%+2.2%0.262%
11/14/2025 ADAR1 Capital Management LLC373,682$710K0.1%N/A0.345%
11/14/2025 Two Sigma Investments LP368,107$699K0.0%-50.9%0.340%
11/14/2025 Bridgeway Capital Management LLC393,319$747K0.0%-11.3%0.363%
11/13/2025 BNP Paribas Financial Markets26,667$51K0.0%+59.0%0.025%
11/12/2025 Dimensional Fund Advisors LP164,244$312K0.0%-20.8%0.152%
11/12/2025 Intech Investment Management LLC38,944$74K0.0%-12.9%0.036%
11/10/2025 Aldebaran Capital LLC987,698$1.88M1.7%-0.6%0.912%
11/10/2025 AXQ Capital LP13,969$27K0.0%N/A0.013%
11/7/2025Vanguard Group Inc.6,515,458$12.38M0.0%-2.2%6.014%
11/7/2025 JPMorgan Chase & Co.758,576$1.44M0.0%+21.6%0.700%
11/6/2025 Rhumbline Advisers91,236$173K0.0%+7.4%0.084%
11/3/2025 New York State Common Retirement Fund48,400$92K0.0%-24.6%0.045%
10/23/2025 SG Americas Securities LLC22,012$42K0.0%-58.7%0.020%
10/21/2025 Three Bridge Wealth Advisors LLC714,823$1.36M0.4%N/A0.660%
10/9/2025 Voya Investment Management LLC17,248$33K0.0%-35.8%0.016%
10/7/2025 Assenagon Asset Management S.A.154,554$294K0.0%-16.3%0.143%
8/27/2025 Squarepoint Ops LLC390,583$555K0.0%+11.9%0.361%
8/15/2025 Engineers Gate Manager LP17,589$25K0.0%-56.3%0.016%
8/15/2025 Bridgeway Capital Management LLC443,319$630K0.0%+53.5%0.409%
$30 stock to buy before Starlink goes public (WATCH NOW!) (Ad)

In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s known for playing his cards “close to the vest”… Is going to give you the name and ticker symbol of a company he believes will skyrocket thanks to the coming Starlink IPO…tc pixel

Click here to watch this short 3-minute video now.
8/15/2025 Bank of America Corp DE72,595$103K0.0%-56.7%0.067%
8/14/2025 Raymond James Financial Inc.277,259$394K0.0%+10.5%0.256%
8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.49,622$70K0.0%N/A0.046%
8/14/2025 The Manufacturers Life Insurance Company 34,131$48K0.0%N/A0.032%
8/14/2025 Qube Research & Technologies Ltd509,350$723K0.0%-62.3%0.470%
8/14/2025 Bollard Group LLC1,352,276$1.92M0.0%-5.0%1.248%
8/13/2025 Marshall Wace LLP2,292,449$3.26M0.0%-0.9%2.116%
8/13/2025 Stonepine Capital Management LLC491,300$698K0.7%-6.9%0.454%
8/13/2025 Invesco Ltd.135,329$192K0.0%+137.1%0.125%
8/13/2025 New York State Common Retirement Fund64,200$91K0.0%N/A0.059%


ACRS Institutional Ownership - Frequently Asked Questions

During the previous two years, 107 institutional investors and hedge funds held shares of Aclaris Therapeutics. The most heavily invested institutionals were Vivo Capital LLC ($25M), Rock Springs Capital Management LP ($16.77M), BML Capital Management LLC ($16.39M), Vanguard Group Inc. ($12.38M), RA Capital Management L.P. ($11.57M), Adage Capital Partners GP L.L.C. ($10.15M), and D. E. Shaw & Co. Inc. ($8.17M).Learn more on Aclaris Therapeutics' institutional investors.

98.34% of Aclaris Therapeutics' stock is owned by institutional investors. Learn more on ACRS's institutional investor holdings.

Of the 88 institutional investors that purchased Aclaris Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Adage Capital Partners GP L.L.C. ($9.63M), Vivo Capital LLC ($8.89M), RA Capital Management L.P. ($4.67M), Decheng Capital LLC ($4.04M), Rock Springs Capital Management LP ($3.47M), Janus Henderson Group PLC ($2.80M), and Marshall Wace LLP ($2.63M).

Institutional investors have bought a total of 11,944,260 shares in the last 24 months. This purchase volume represents approximately $30.84M in transactions.

Of the 31 institutional investors that sold Aclaris Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($2.78M), Vivo Capital LLC ($2.22M), Adage Capital Partners GP L.L.C. ($1.91M), Marshall Wace LLP ($1.25M), Renaissance Technologies LLC ($1.12M), Bollard Group LLC ($992.55K), and Logos Global Management LP ($900K).

Institutional investors have sold a total of 14,707,685 shares in the last 24 months. This volume of shares sold represents approximately $40.81M in transactions.



This page (NASDAQ:ACRS) was last updated on 5/21/2026 by MarketBeat.com Staff.
From Our Partners